Clinical Study in Healthy Men to Investigate the Uptake of Buprenorphine and Its Elimination From the Body After Dermal Application as Patches for 96 Hours and for 72 Hours

Conditions:   Pain;   Pharmacokinetics Intervention:   Drug: Transtec 35 µg/hour transdermal patch Sponsor:   Grünenthal GmbH Completed

Source: ClinicalTrials.gov - December 10, 2018 Category: Research Source Type: clinical trials